Boston Scientific Profit, Sales Rise but Issues Soft Guidance

Wednesday, February 4, 2026 at 2:19 PM

#Boston Scientific #Earnings #Guidance #Sales

Boston Scientific reported a rise in fourth-quarter net income and sales, with a 16% increase in sales to $5.29 billion.

However, the company issued a soft forecast for the upcoming year, which may impact investor sentiment.

Markets★★Similarity: 69% · 26d ago

Novartis Forecasts Profitability Hit From Generic Drug Competition in U.S.

The pharma major said it faces the largest drug-patent expiry headwind in its history this year.

Markets★★Similarity: 69% · 28d ago

Teradyne Profit Rises as Sales Surge on AI-Related Demand

The company, which makes testing equipment for semiconductors and robotics, posted a fourth-quarter profit of $257.2 million, up from $146.3 million a year earlier.

Tech★★Similarity: 68% · 20d ago

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.

Markets★★Similarity: 68% · 26d ago

GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

GE HealthCare Technologies said profit fell in the fourth quarter, despite higher revenue, as the company continues to operate in what Chief Executive Peter Arduini called a dynamic macroeconomic environment.

Data sourced from public RSS feeds and News APIs.

Boston Scientific Profit, Sales Rise but Issues Soft Guidance

Related Articles

Novartis Forecasts Profitability Hit From Generic Drug Competition in U.S.

Teradyne Profit Rises as Sales Surge on AI-Related Demand

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

Boston Scientific Profit, Sales Rise but Issues Soft Guidance

Related Articles

Novartis Forecasts Profitability Hit From Generic Drug Competition in U.S.

Teradyne Profit Rises as Sales Surge on AI-Related Demand

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue